Elevance Health, Inc. (ELV) reported first-quarter 2024 adjusted earnings of $10.64 per share, which surpassed the Zacks Consensus Estimate by 0.9%. The bottom line climbed 12.5% year over year.Operating revenues rose 0.9% year over year to almost $42.3 billion in the quarter under review. However, the top line missed the consensus mark by 0.4%.The strong first-quarter earnings benefited on the back of lower-than-expected expenses, premium rate increases and growth in the Carelon brand. However, the upside ...